Registers refreshed 2026-11-08.See refresh dates
Netherlands

Cergentis

Yalelaan 62, 3584 CM, UTRECHT, Netherlands

RvA L671ISO/IEC 17025Register refreshed 2026-11-08

We check which accredited labs can do it, starting with this one, and send you a short comparison of time and rough cost within three working days.

  • Free. No lab gets your details until you choose.
Scope lines
2
RvA certificate
1
Site in our directory
1
RvA accredited scope

What this lab is accredited for

We found no published test standard numbers in this lab’s scope. The full scope as published is below.

Only this lab. Searches the method, matrix and range of each of the 2 scope lines.

RvA certificate L671 · 2 lines

LineMethodMatrixRange
1-Cells isolated from bone marrow, spleen, liver or kidney; White blood cells isolated from fresh blood samples; Cultured T-Cells, ESCs and iPSCs; Cell lines (for example CHO, HELA, HEK293T); Yeast cells; Cells isolated from embryos or whole fish; Vectors
Show page text

Extracted from the scope document; tables may not line up. View scope for the original.

Annex to declaration of accreditation (scope of accreditation) Normative document: EN ISO/IEC 17025:2017 Registration number: L 671 of Cergentis B.V. trading as Solvias NL Department Services This annex is valid from: 23-10-2025 to 01-02-2030 Replaces annex dated: 09-10-2024 Location(s) where activities are performed under accreditation Head Office Yalelaan 62 3584 CM Utrecht The Netherlands Dutch Accreditation Council RvA Page 1 of 2 This annex has been approved by the Board of the Dutch Accreditation Council, on its behalf, J.A.W.M. de Haas Location Abbreviation/ location code Yalelaan 62 3584 CM Utrecht The Netherlands U No. Material or product Type of activity1 Internal reference number Location 1. . Cells isolated from bone marrow, spleen, liver or kidney, White blood cells isolated from fresh blood samples, Cultured T-Cells, ESCs and iPSCs, Cell lines (for example CHO, HELA, HEK293T), Yeast cells, Cells isolated from embryos or whole fish, Vectors Determination of the integrity of the transgene vector sequence; next generation sequencing (NGS) and bio-informatic data analysis ASOP-0951, ASOP-0953, ASOP- 0941, ASOP-0937, ASOP-0950, OSOP-0708, OSOP-0709 in house method U 1 If there is a referral to a code starting with NAW, NAP, EA or IAF, this concerns a scheme mentioned on RvA-BR010-lijst. If no date or version number is mentioned for a normative document, the accreditation concerns the most current version of the document or scheme.
-
2-Cells isolated from bone marrow, spleen, liver or kidney, White blood cells isolated from fresh blood samples, Cultured T-Cells, ESCs and iPSCs, Cell lines (for example CHO, HELA, HEK293T), Yeast cells, Cells isolated from embryos or whole fish; Isolated white blood cells and organoids
Show page text

Extracted from the scope document; tables may not line up. View scope for the original.

Annex to declaration of accreditation (scope of accreditation) Normative document: EN ISO/IEC 17025:2017 Registration number: L 671 of Cergentis B.V. trading as Solvias NL Department Services This annex is valid from: 23-10-2025 to 01-02-2030 Replaces annex dated: 09-10-2024 Dutch Accreditation Council RvA Page 2 of 2 No. Material or product Type of activity1 Internal reference number Location 2. . Cells isolated from bone marrow, spleen, liver or kidney, White blood cells isolated from fresh blood samples, Cultured T-Cells, ESCs and iPSCs, Cell lines (for example CHO, HELA, HEK293T), Yeast cells, Cells isolated from embryos or whole fish Determination of the vector integration site(s) and breakpoint sequences between the vector and genome; next generation sequencing (NGS) and bio- informatic data analysis ASOP-0951, ASOP-0953, ASOP- 0941, ASOP-0937, ASOP-0950, OSOP-0708, OSOP-0709 in house method U 3. Determination of the presence of structural variants surrounding the vector integration site(s); next generation sequencing (NGS) and bio-informatic data analysis ASOP-0951, ASOP-0953, ASOP- 0941, ASOP-0937, ASOP-0950, OSOP-0708, OSOP-0709 in house method U 4. Determination of transgene components; next generation sequencing (NGS), comparison with reference libraries of common vector elements and bio-informatic data analysis ASOP-0951, ASOP-0953, ASOP- 0941, ASOP-0937, ASOP-0950, OSOP-0708, OSOP-0709 in house method U 5. Determination of gene editing events in endogenous loci; next generation sequencing (NGS) and bio-informatic data analysis ASOP-0951, ASOP-0953, ASOP- 0941, ASOP-0937, ASOP-0950, OSOP-0708, OSOP-0709 in house method U 6. Isolated white blood cells and organoids Determination of integration site(s) in heterogeneous cell populations; next generation sequencing (NGS) and bio- informatic data analysis ASOP-0951, ASOP-0953, ASOP- 0941, ASOP-0937, ASOP-0950, OSOP-0708, OSOP-0709 in house method U
-

Ranges are reproduced from the accredited scope document as published, and only where we found that range printed in the document for the line. Otherwise the cell reads “See scope document”. An absent range means the register did not state one. Line numbers are ours, for cross-reference; they follow the order of the scope document.

Location

Yalelaan 62, UTRECHT, 3584 CM, NL

52.08301, 5.18032

Open in Maps

Accreditation data refreshed from the RvA register on .

This page mirrors a public register. For a purchasing, audit or regulatory decision, confirm against the RvA entry linked above.